Stock listing

NASDAQ:AVDL Avadel Pharmaceuticals PLC Stock

Follow Avadel Pharmaceuticals PLC into a list and get an email when it puts out news.

Last close · NASDAQ:AVDL

$21.63 USD

Close on Feb 10, 2026 · No longer trades

Jun 7, 1996 to last close +84.1% · monthly closes, Jun 7, 1996 – Feb 10, 2026
Lowest – highest close
$0.94 – $42.85 USDSince Jun 7, 1996 · lowest Oct 8, 2001 · highest Sep 19, 2003

Delisted NASDAQ:AVDL no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:AVDL
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Avadel Pharmaceuticals PLC on 6ix

Decks
28 decks · latest Aug 7, 2025

Decks

DeckKindSlidesDate
Q2 2025 Earnings PresentationEarnings25 slidesAug 7, 2025
Q1 2025 Earnings PresentationEarnings16 slidesMay 7, 2025
Q4 2024 Earnings PresentationEarnings16 slidesJan 8, 2025
Technical Presentation (April 2020)Technical24 slidesApr 27, 2020
Investor Presentation (January 2020)Investor deck15 slidesJan 10, 2020
Piper Jaffray Healthcare Conference December 2019Conference14 slidesDec 5, 2019
Technical Presentation (September 2019)Technical17 slidesSep 25, 2019
Investor Presentation (September 2019)Investor deck14 slidesSep 24, 2019
Q3 2018 Earnings PresentationEarnings10 slidesNov 5, 2018
Q2 2018 Earnings PresentationEarnings24 slidesAug 7, 2018
All 28 decks
DeckKindSlidesDate
Q1 2018 Earnings PresentationEarnings21 slidesMay 2, 2018
FY2017 Earnings PresentationEarnings25 slidesMar 8, 2018
Investor Presentation (February 2018)Investor deck29 slidesFeb 13, 2018
Investor Presentation (November 2017)Investor deck85 slidesNov 13, 2017
Q3 2017 Earnings PresentationEarnings17 slidesNov 8, 2017
Investor Presentation (September 2017)Investor deck19 slidesSep 6, 2017
Q1 2017 Earnings PresentationEarnings18 slidesMay 11, 2017
Investor Presentation (March 2017)Investor deck26 slidesMar 17, 2017
FY2016 Earnings PresentationEarnings19 slidesMar 7, 2017
Investor Presentation (January 2017)Investor deck26 slidesJan 11, 2017
Flamel Technologies — Q3 2016 Earnings PresentationEarnings18 slidesNov 7, 2016
Flamel Technologies — Investor Presentation (October 2016)Investor deck37 slidesOct 20, 2016
Flamel Technologies — Investor Day (September 2016)Investor day66 slidesSep 26, 2016
Flamel Technologies — Q2 2016 Earnings PresentationEarnings18 slidesAug 8, 2016
Flamel Technologies — Investor Presentation (June 2016)Investor deck31 slidesJun 7, 2016
Flamel Technologies — Investor Presentation (May 2016)Investor deck30 slidesMay 4, 2016
Flamel Technologies — Investor Presentation (March 2016)Investor deck37 slidesMar 14, 2016
Flamel Technologies — Investor Presentation (February 2016)Investor deck37 slidesFeb 23, 2016

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Susan Rodriguez
Other companies: Monopar Therapeutics Inc. (Chief Commercial and Strategy Officer · Since at least Mar 2, 2026); Veradigm Inc. (Director · Since at least Feb 17, 2023); Heron Therapeutics, Inc. (Director · Sep 20, 2021 – Jan 31, 2025 · Past); Ardelyx, Inc. (Chief Commercial Officer · May 18, 2020 – May 21, 2024 · Past)
Chief Operating Officer · Since at least May 13, 2025
Douglas J. Williamson
Other companies: Vistagen Therapeutics, Inc. (Director · Since at least Jul 29, 2026); ACADIA Pharmaceuticals Inc. (Executive VP, Research & Dev · Feb 1, 2023 – Feb 10, 2023 · Past)
Chief Medical Officer · Feb 14, 2022 – Feb 14, 2022 · Past
Eric J Ende
Other companies: Matinas BioPharma Holdings, Inc. (Director · Nov 14, 2022 – Nov 1, 2023 · Past); NeuBase Therapeutics Inc (Director · Sep 9, 2022 – Sep 9, 2022 · Past)
Director · Since at least May 27, 2022
Linda Palczuk
Other companies: Verrica Pharmaceuticals Inc. (Chief Operating Officer · Jun 14, 2018 – Feb 28, 2019 · Past); Osiris Therapeutics Inc (President & CEO · Jul 10, 2017 – Jul 10, 2017 · Past)
Director · Since at least Jul 18, 2018
Naseem Amin
Other companies: Bellerophon Therapeutics Inc (Director · Jun 29, 2015 – Jun 7, 2023 · Past)
Director · Since at least May 17, 2024
Richard J Kim
Other companies: Intercept Pharmaceuticals Inc (President US Comm & Strat Mktg · May 1, 2017 – Dec 31, 2020 · Past)
Chief Commercial Officer · Feb 15, 2021 – Feb 20, 2024 · Past
Benoit Van AsscheDirector · Jun 28, 2017 – Jul 9, 2018 · Past
Gregory J DivisChief Executive Officer, Director · Since at least Feb 12, 2026
Marcus W ElrodVP, Sales · Aug 29, 2016 – Jan 3, 2017 · Past
Mark Anthony McCamishDirector · Since at least Jul 29, 2025
All 13 people
PersonSeat
Peter J ThorntonDirector · Since at least Jun 28, 2017
Phillandas T ThompsonSee Remarks · Dec 12, 2017 – Mar 7, 2019 · Past
Thomas S McHughChief Financial Officer · Since at least Dec 2, 2019

Open People

Log in to ask 6ix AI your own questions about Avadel Pharmaceuticals PLC.